Insmed Inc (INSM): Next-Year EPS Estimate 117.59%
As of 2026-06-04, Insmed Inc (INSM) has a next-year EPS growth estimate of 117.59%.
On 2026-05-20, analyst consensus for INSM's next-year EPS growth shifted from 116.82% to 117.59% — a positive change of 0.77 percentage points. The revised estimate has been sustained across 12 subsequent trading sessions. Current-year growth is projected at 56.56%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 117.59%
- EPS growth this year
- 56.56%
- EPS next quarter (est)
- -$0.80
- Last price
- $104.92
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 117.59% | 56.56% | -$0.80 | $104.92 |
| 2026-06-03 | 117.59% | 56.57% | -$0.80 | $103.86 |
| 2026-06-02 | 117.59% | 56.57% | -$0.80 | $103.73 |
| 2026-06-01 | 117.59% | 56.57% | -$0.80 | $106.03 |
| 2026-05-31 | 117.59% | 56.57% | -$0.80 | $106.91 |
| 2026-05-28 | 117.59% | 56.57% | -$0.80 | $108.37 |
| 2026-05-27 | 117.59% | 56.57% | -$0.80 | $106.40 |
| 2026-05-26 | 117.59% | 56.57% | -$0.80 | $108.87 |
| 2026-05-25 | 117.59% | 56.57% | -$0.80 | $106.24 |
| 2026-05-24 | 117.59% | 56.57% | -$0.80 | $106.24 |
| 2026-05-21 | 117.59% | 56.57% | -$0.80 | $109.53 |
| 2026-05-20 | 117.59% | 56.57% | -$0.80 | $107.91 |
| 2026-05-19 | 116.82% | 56.34% | -$0.80 | $107.41 |
| 2026-05-18 | 116.82% | 56.34% | -$0.80 | $107.15 |
| 2026-05-17 | 116.82% | 56.34% | -$0.80 | $109.14 |
| 2026-05-14 | 119.73% | 56.09% | -$0.80 | $115.62 |
| 2026-05-13 | 119.15% | 56.66% | -$0.80 | $117.14 |
| 2026-05-12 | 119.15% | 56.66% | -$0.80 | $116.00 |
| 2026-05-11 | 119.15% | 56.66% | -$0.80 | $103.89 |
| 2026-05-10 | 119.15% | 56.66% | -$0.80 | $101.35 |
| 2026-05-07 | 139.59% | 58.46% | -$0.78 | $105.00 |
| 2026-05-06 | 146.35% | 60.47% | -$0.96 | $137.09 |
| 2026-05-05 | 146.35% | 60.47% | -$0.96 | $139.44 |
| 2026-05-04 | 146.35% | 60.47% | -$0.96 | $140.01 |
| 2026-05-03 | 143.55% | 59.65% | -$0.97 | $133.26 |
| 2026-04-30 | 143.55% | 59.65% | -$0.97 | $136.33 |
| 2026-04-29 | 143.55% | 59.65% | -$0.97 | $135.03 |
| 2026-04-28 | 143.81% | 59.78% | -$0.96 | $134.94 |
| 2026-04-27 | 143.81% | 59.78% | -$0.96 | $135.98 |
| 2026-04-26 | 143.81% | 59.78% | -$0.96 | $135.17 |
Recent News
- JPMorgan sees biotech sector at inflection point, resumes coverage on 14 FirmsInvesting.com
- Insmed to Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE Results from Phase 3b ENCORE Study, at the American Thoracic Society International Conference 2026PR Newswire
- Insmed freezes Brinsupris HS programme on Phase II failureClinical Trials Arena
- Novo underprices Lilly with higher-dose Wegovy; Insmed absorbs expected study failureBioPharma Dive
- Insmed Provides Clinical Update on Phase 2b CEDAR StudyPR Newswire
- Insmed Provides Clinical Update on Phase 2b CEDAR StudyPR Newswire
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Insmed Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Insmed Inc (INSM) has a next-year EPS growth estimate of 117.59%, based on analyst consensus.
When was the latest EPS estimate revision for INSM?▾
The most recent revision occurred on 2026-05-20, when analysts adjusted the next-year EPS growth estimate from 116.82% to 117.59%.
What sector and industry does Insmed Inc belong to?▾
Insmed Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. INSM appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Insmed Inc (INSM) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports